Integer (ITGR) Competitors

$114.16
+1.02 (+0.90%)
(As of 05/9/2024 ET)

ITGR vs. MASI, TMDX, LIVN, CNMD, SLNO, INMD, PACS, INSM, SEM, and PBH

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Masimo (MASI), TransMedics Group (TMDX), LivaNova (LIVN), CONMED (CNMD), Soleno Therapeutics (SLNO), InMode (INMD), PACS Group (PACS), Insmed (INSM), Select Medical (SEM), and Prestige Consumer Healthcare (PBH). These companies are all part of the "medical" sector.

Integer vs.

Masimo (NASDAQ:MASI) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, community ranking, institutional ownership, analyst recommendations and media sentiment.

Integer has lower revenue, but higher earnings than Masimo. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Masimo$2.05B3.21$81.50M$1.5182.23
Integer$1.63B2.34$90.65M$2.8939.50

Integer has a net margin of 6.01% compared to Integer's net margin of 3.98%. Integer's return on equity of 13.77% beat Masimo's return on equity.

Company Net Margins Return on Equity Return on Assets
Masimo3.98% 13.77% 5.98%
Integer 6.01%11.25%5.69%

Masimo received 78 more outperform votes than Integer when rated by MarketBeat users. Likewise, 63.84% of users gave Masimo an outperform vote while only 63.39% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
MasimoOutperform Votes
452
63.84%
Underperform Votes
256
36.16%
IntegerOutperform Votes
374
63.39%
Underperform Votes
216
36.61%

86.0% of Masimo shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 9.7% of Masimo shares are owned by company insiders. Comparatively, 2.0% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Masimo had 32 more articles in the media than Integer. MarketBeat recorded 40 mentions for Masimo and 8 mentions for Integer. Masimo's average media sentiment score of 0.81 beat Integer's score of 0.36 indicating that Integer is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Masimo
9 Very Positive mention(s)
6 Positive mention(s)
15 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral
Integer
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Masimo presently has a consensus target price of $138.71, suggesting a potential upside of 11.72%. Integer has a consensus target price of $120.50, suggesting a potential upside of 5.55%. Given Integer's higher possible upside, analysts clearly believe Masimo is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Masimo
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
Integer
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Masimo has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500.

Summary

Masimo beats Integer on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$3.82B$3.26B$5.15B$17.78B
Dividend YieldN/A1.68%2.78%3.51%
P/E Ratio39.5010.02167.2625.12
Price / Sales2.3462.192,372.2511.03
Price / Cash14.0166.1233.8715.59
Price / Book2.503.975.335.09
Net Income$90.65M$87.99M$105.45M$968.04M
7 Day Performance3.86%0.46%0.54%2.59%
1 Month Performance-4.06%-8.61%-3.47%-0.55%
1 Year Performance44.21%1.64%3.76%103.03%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MASI
Masimo
4.635 of 5 stars
$134.41
-1.3%
$137.43
+2.2%
-32.6%$7.11B$2.05B89.015,200Earnings Report
Analyst Forecast
News Coverage
TMDX
TransMedics Group
1.722 of 5 stars
$94.13
-3.2%
$102.00
+8.4%
+70.6%$3.08B$241.62M-122.25584Insider Selling
LIVN
LivaNova
0.8466 of 5 stars
$55.75
-0.7%
$64.40
+15.5%
+32.5%$3.01B$1.15B174.222,900
CNMD
CONMED
4.9778 of 5 stars
$67.99
+1.1%
$107.86
+58.6%
-42.2%$2.09B$1.24B26.054,000Insider Buying
SLNO
Soleno Therapeutics
3.638 of 5 stars
$44.66
-1.9%
$55.60
+24.5%
+1,002.8%$1.49BN/A-15.0433Upcoming Earnings
News Coverage
Positive News
High Trading Volume
INMD
InMode
3.6156 of 5 stars
$17.19
-0.2%
$32.80
+90.8%
-47.1%$1.44B$492.05M7.47581
PACS
PACS Group
0 of 5 stars
$24.97
+1.1%
N/AN/A$3.75B$3.11B0.0032,433Upcoming Earnings
INSM
Insmed
4.1427 of 5 stars
$24.72
-1.1%
$44.92
+81.7%
+39.4%$3.67B$305.21M-4.63373News Coverage
Gap Up
SEM
Select Medical
4.3975 of 5 stars
$28.36
+1.3%
$34.40
+21.3%
+14.2%$3.64B$6.66B14.8554,600
PBH
Prestige Consumer Healthcare
4.0942 of 5 stars
$71.75
+0.0%
$110.00
+53.3%
+20.4%$3.56B$1.13B-43.75560Upcoming Earnings

Related Companies and Tools

This page (NYSE:ITGR) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners